Press release
Future of the Global Genomic Selection Platform Market: Trends, Innovations, and Key Forecasts Through 2034
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.Genomic Selection Platform Market Size Growth Forecast: What to Expect by 2025?
The market size for genomic selection platforms has seen swift expansion in the last few years. This growth is expected to continue, increasing from $1.94 billion in 2024 to $2.27 billion in 2025, with a compound annual growth rate (CAGR) of 17.3%. Several factors have contributed to this growth throughout the historical period, including advancements in agricultural biotechnology, the increasing prominence of quantitative genetics in breeding programs, a heightened emphasis on disease resistance in crops and livestock, the proliferation of collaborative research programs, and the escalating pressures from disease and fluctuating climate conditions.
How Will the Genomic Selection Platform Market Size Evolve and Grow by 2029?
The market for genomic selection platforms is predicted to experience a significant surge in the ensuing years, with the market valuation projected to reach $4.25 billion by 2029, showing a compound annual growth rate (CAGR) of 16.9%. The expected growth during this timeframe can be ascribed to factors such as the escalating worldwide demand for food, the development of precision farming, increased emphasis on sustainable breeding practices, the progress in livestock genomics, as well as the expansion of contract breeding and genomic services. Key trends to watch out for during this forecasted period encompass progressions in next-generation sequencing (NGS), digital agriculture tool integrations, artificial intelligence and machine learning integrations, the embracement of cloud-based genomic data platforms, and the amalgamation of multi-omics data.
View the full report here:
https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report
What Drivers Are Propelling the Growth of Genomic Selection Platform Market Forward?
The growing implementation of personalized medicine is set to boost the expansion of the genomic selection platform market in the future. Personalized medicines take into consideration an individual's unique genetic profile, lifestyle and environmental factors to strategize treatment and prevention. The rising use of personalized medicines is hugely attributed to developments in genomics, making precise identification of genetic variations and individualized treatments possible. Genomic selection platforms, by providing accurate genomic insights, prove invaluable in personalizing therapies to patient requirements, thus limiting trial-and-error in treatment selection, enhancing treatment efficacy and improving patient outcomes. For example, based on data from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023; a considerable increase from the 12 approved in 2022. Thus, increased receptivity towards personalized medicine is fuelling the expansion of the genomic selection platform market. Accelerating the genomic selection platform market further is the rise in crop yields, critical for improving agricultural productivity and efficient breeding. Crop yield, i.e., the agricultural produce per land unit (such as grains, fruits, or vegetables), is witnessing growth due to innovations in agricultural biotechnology reinforcing plant genetics and resilience. Genomic selection platforms boost crop yields by precision selection of superior plant species, making them indispensable for contemporary agriculture and breeding programs. These platforms also reduce the cost and time spent on traditional breeding by offering accurate genetic predictions, thereby enhancing farm productivity and food security. For example, data from the Department for Environment, Food and Rural Affairs, a UK-based government agency, show that total cereal production in the UK, including wheat, barley, oats, and minor cereals, reached 24.3 million tonnes in 2022, marking an 8% increase from 2021. Thus, escalating crop yields are fuelling the expansion of the genomic selection platform market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28237&type=smp
Which Emerging Trends Are Transforming the Genomic Selection Platform Market in 2025?
In the market sector for genomic selection platforms, leading corporations are concentrating their efforts on creating innovative solutions, including targeted sequencing platforms. The intent of these platforms is to enhance trait prediction and speed up breeding programs. These platforms are a type of genomic technology designed to focus on sequencing specific genome areas instead of the whole genome. For instance, in October 2024, Element Biosciences Inc., a life sciences technology company based in the United States, introduced Trinity. This significant leap forward in targeted sequencing platform technology simplifies exome capture, knitting together traditionally multifaceted steps into their AVITI System. Trinity eliminates the need for specialized equipment and decreases up to five hours of manual labor. It also offers a one-hour hybridization opportunity for results the same day, making it perfect for studies with tight timelines. Trinity can also adapt to support customized panels across a broad range of applications such as oncology, respiratory diseases, and minimal residual disease (MRD). Its capabilities in providing faster, economical, and accessible sequencing, representing the first significant progress in exome capture.
What Are the Key Segments in the Genomic Selection Platform Market?
The genomic selection platform market covered in this report is segmented as
1) By Component: Software, Hardware, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Plant Breeding, Animal Breeding, Human Genomics, Other Applications
4) By End-User: Research Institutes, Biotechnology Companies, Agricultural Organizations, Other End Users
Subsegments:
1) By Software: Genomic Data Management Software, Bioinformatics And Statistical Analysis Tools, DNA Or RNA Sequencing Data Processing Software, Genomic Prediction And Modeling Software, Cloud-Based Genomic Platforms, Workflow Automation And Integration Tools
2) By Hardware: Next-Generation Sequencing (NGS) Systems, Polymerase Chain Reaction (PCR) Instruments, Microarray Analyzers, High-Performance Computing (HPC) Systems, Data Storage Servers, Laboratory Automation And Robotics
3) By Services: Sequencing And Genotyping Services, Data Analysis And Interpretation Services, Cloud Hosting & Data Storage Services, Custom Bioinformatics Solutions, Training And Technical Support Services, Consulting And Implementation Services
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28237&type=smp
Who Are the Key Players Shaping the Genomic Selection Platform Market's Competitive Landscape?
Major companies operating in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., and Enigma Genomics Inc.
What Geographic Markets Are Powering Growth in the Genomic Selection Platform Market?
North America was the largest region in the genomic selection platform market in 2024. The regions covered in genomic selection platform report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28237
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Future of the Global Genomic Selection Platform Market: Trends, Innovations, and Key Forecasts Through 2034 here
News-ID: 4214397 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Genomic
Genomic Cancer Testing Market Insights on the Impact of Genomic Profiling and Bi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic Cancer Testing Market - (By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR),…
Japan Genomic Medicine Market 2025 | Hospitals & clinics lead with 53% share, ad …
Leander, Texas and Tokyo, Japan - Nov.27.2025
As per DataM intelligence research report" Japan Genomic Medicine Market to expected to grow at High CAGR during forecast period 2024-2031." Personalized treatment approaches and advanced research investments are boosting genomic medicine adoption in Japan.
Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/japan-genomic-medicine-market?Prasad
Japan: Recent Industry Developments
✅ In November 2025, Takeda Pharmaceutical advanced genomic-guided therapies for rare hereditary diseases, improving precision in…
Genomic and Epigenomic Profiling Market Development Driven by Investment in Biot …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic & Epigenomic Profiling Market Size, Share & Trends Analysis Report, By Type (Genomic Profiling and Epigenomic Profiling), By Application (Clinical Diagnostics, Agriculture & Animal Research, and Drug Discovery & Development), By Technology (NGS, PCR-based, and Microarray), By End-use (Hospitals, Pharmaceuticals, and Research Institutes),-Market Outlook And Industry Analysis 2034"
Genomic & Epigenomic Profiling Market Size is…
Emerging Trends Influencing The Growth Of The Genomic Biomarker Market: Technolo …
The Genomic Biomarker Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Genomic Biomarker Market Size Expected to Be by 2034?
The size of the genomic biomarker market has witnessed swift expansion in the recent past. It is slated to expand from a…
Genomic Biomarker Market Future Business Opportunities 2025-2032 | Liquid Genomi …
Latest Report, titled "Genomic Biomarker Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Genomic Biomarker market has been expanding significantly…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
